The deal gives WCG a leader in technology-enabled clinical trial solutions, it said in a news release, including site communication platform InvestigatorSpace. Financial terms were not disclosed.
“With a host of services that fully integrate clinical trial training and communication, from safety letter notification to regulatory document exchange, Trifecta adds another dimension to WCG’s compelling value proposition,” WCG Executive Chairman and CEO Donald A. Deieso said in a prepared statement. “This acquisition is part of our effort to pursue strategic opportunities that allow us to expand and enhance our offerings in anticipation of our customers’ needs.”
Trifecta will now be known as WCG Trifecta and will retain its leadership, Los Angeles headquarters and other locations in the U.S. and Japan.